3 Firms Win Lead Counsel Roles In Insulin Price-Fixing MDL

Law360 (September 23, 2020, 6:39 PM EDT) -- A New Jersey federal judge agreed Tuesday to give lead interim counsel roles to attorneys Dianne M. Nast of NastLaw LLC, Michael L. Roberts of Roberts Law Firm PA and Don Barrett of Barrett Law Group PA in antitrust litigation accusing Eli Lilly, Novo Nordisk and Sanofi-Aventis of scheming to drive up insulin drug prices.

The three attorneys and their firms represent defunct Illinois-based wholesaler FWK Holdings LLC in a proposed class action claiming direct purchasers overpaid for insulin drugs due to the manufacturers and pharmacy benefit managers colluding to artificially inflate insulin medicine costs.

U.S. District Judge Brian R. Martinotti,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!